The Oncology Institute, Inc. (TOI) Q4 2024 Annual Earnings
TOI·Reported March 24, 2025·After market close
The Oncology Institute, Inc. reported Q4 2024 revenue of $100.3M, missed analyst consensus of $109.1M by $8.9M. Diluted EPS came in at $-0.14, missed the $-0.08 consensus by $0.06.
Revenue
$100.3Mmissed by $8.9M
Consensus: $109.1MDiluted EPS
$-0.14missed by $0.06
Consensus: $-0.08
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about The Oncology Institute, Inc.'s Q4 2024 earnings report.
The Oncology Institute, Inc. (TOI) reported Q4 2024 earnings on March 24, 2025 after market close.
The Oncology Institute, Inc. reported revenue of $100.3M and diluted EPS of $-0.14 for Q4 2024.
Revenue missed the consensus estimate of $109.1M by $8.9M. EPS missed the consensus estimate of $-0.08 by $0.06.
You can read the 10-K periodic report (0001799191-25-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.